130 related articles for article (PubMed ID: 9536461)
1. Modulation of monoamine oxidase activity in different brain regions and platelets following exposure of rats to methylmercury.
Chakrabarti SK; Loua KM; Bai C; Durham H; Panisset JC
Neurotoxicol Teratol; 1998; 20(2):161-8. PubMed ID: 9536461
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity.
Yáñez M; Fraiz N; Cano E; Orallo F
Biochem Biophys Res Commun; 2006 Jun; 344(2):688-95. PubMed ID: 16631124
[TBL] [Abstract][Full Text] [Related]
3. Effect of plasma from premenstrual syndrome and control patients on human platelet and rat brain synaptosome monoamine oxidase B activity.
Ashby CR; Carr LA; Cook C; Steptoe MM; Franks DD
Neuropsychobiology; 1992; 25(3):121-5. PubMed ID: 1407477
[TBL] [Abstract][Full Text] [Related]
4. Effects of prenatal methylmercury exposure on brain monoamine oxidase activity and neurobehaviour of rats.
Beyrouty P; Stamler CJ; Liu JN; Loua KM; Kubow S; Chan HM
Neurotoxicol Teratol; 2006; 28(2):251-9. PubMed ID: 16490344
[TBL] [Abstract][Full Text] [Related]
5. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
Yáñez M; Fraiz N; Cano E; Orallo F
Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740
[TBL] [Abstract][Full Text] [Related]
6. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
Fagervall I; Ross SB
J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
[TBL] [Abstract][Full Text] [Related]
7. Differential changes in monoamine oxidase A and B activity in the aging rat brain.
Benedetti MS; Keane PE
J Neurochem; 1980 Nov; 35(5):1026-32. PubMed ID: 7452302
[TBL] [Abstract][Full Text] [Related]
8. Brain monoaminergic neurotransmission parameters in weanling rats after perinatal exposure to methylmercury and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153).
Castoldi AF; Blandini F; Randine G; Samuele A; Manzo L; Coccini T
Brain Res; 2006 Sep; 1112(1):91-8. PubMed ID: 16904659
[TBL] [Abstract][Full Text] [Related]
9. Effect of styrene on monoamine oxidase B activity in rat brain.
Coccini T; Randine G; Li B; Manzo L; Costa LG
J Toxicol Environ Health A; 1999 Jan; 56(1):59-68. PubMed ID: 9923754
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
[TBL] [Abstract][Full Text] [Related]
11. Regional distribution of dopamine beta-hydroxylase and monoamine oxidase in the brains of rats exposed to manganese.
Subhash MN; Padmashree TS
Food Chem Toxicol; 1990 Aug; 28(8):567-70. PubMed ID: 2242831
[TBL] [Abstract][Full Text] [Related]
12. [Effect of madecassoside on depression behavior of mice and activities of MAO in different brain regions of rats].
Liu MR; Han T; Chen Y; Qin LP; Zheng HC; Rui YC
Zhong Xi Yi Jie He Xue Bao; 2004 Nov; 2(6):440-4. PubMed ID: 15539023
[TBL] [Abstract][Full Text] [Related]
13. Regional action of brofaromine on rat brain MAO-A and MAO-B.
Gerardy J; Dresse A
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1141-55. PubMed ID: 9829294
[TBL] [Abstract][Full Text] [Related]
14. Methylmercury-induced elevations in intrasynaptosomal zinc concentrations: an 19F-NMR study.
Denny MF; Atchison WD
J Neurochem; 1994 Jul; 63(1):383-6. PubMed ID: 8207443
[TBL] [Abstract][Full Text] [Related]
15. Developmental methylmercury administration alters cerebellar PSA-NCAM expression and Golgi sialyltransferase activity.
Dey PM; Gochfeld M; Reuhl KR
Brain Res; 1999 Oct; 845(2):139-51. PubMed ID: 10536193
[TBL] [Abstract][Full Text] [Related]
16. Neurocatin-induced inhibition of monoamine oxidase A in rat brain synaptosomes.
Fernandez-Novoa L; Pastuszko A; Wilson DF
Biochem Pharmacol; 1991 Nov; 42(12):2351-4. PubMed ID: 1764118
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity.
Ali SF; LeBel CP; Bondy SC
Neurotoxicology; 1992; 13(3):637-48. PubMed ID: 1475065
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of mitochondrial and synaptosomal monoamine oxidase in monkey brain.
Egashira T; Yamamoto T; Yamanaka Y
Jpn J Pharmacol; 1984 Feb; 34(2):211-9. PubMed ID: 6431160
[TBL] [Abstract][Full Text] [Related]
19. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
[TBL] [Abstract][Full Text] [Related]
20. Effects of methylmercury on neurotransmitter release from rat brain synaptosomes.
Minnema DJ; Cooper GP; Greenland RD
Toxicol Appl Pharmacol; 1989 Jul; 99(3):510-21. PubMed ID: 2568702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
